Uitgebreid zoeken

Iain James Mackay is Chief Financial Officer & Executive Director bij GlaxoSmithKline Plc en Director & Finance Director bij HSBC Holdings PLC (Hong Kong). Hij is tevens lid van de rechtbank van de Universiteit van Aberdeen en lid van The Institute of Chartered Accountants of Scotland en zetelt in de raad van bestuur van 5 andere ondernemingen. Voordien bekleedde hij de functie van Executive Director & Group Finance Director bij HSBC Holdings Plc. Chief Financial Officer van The HongKong & Shanghai Banking Corp. Ltd. Chief Financial Officer bij HSBC Asia Pacific Holdings (UK) Ltd. CFO & Senior Executive Vice President bij HSBC Finance Corp. en Chief Financial Officer & Senior EVP bij HSBC North America Holdings, Inc. (die alle dochterondernemingen zijn van HSBC Holdings Plc.), Finance Director-Europe, Africa & South East Asia bij Dowell Schlumberger, Chief Financial Officer & Vice President voor Global Life Sciences Solutions Manufacturing UK Ltd. en Chief Financial Officer & Vice President bij GE Consumer Finance, Inc. De heer Mackay is afgestudeerd aan de Universiteit van Aberdeen.

Iain Mackay currently works at GB Snowsport Ltd., as Director.

Michelle M.
MacKay is currently the Chief Executive Officer & Director at Cushman & Wakefield Plc, the Chief Executive Officer at Cushman & Wakefield, Inc., the Chief Executive Officer at Cushman & Wakefield Sweden AB, and the Co-President, Chief Operating Officer & Director at Cushman & Wakefield Debenham Tie Leung Ltd.
Previously, she served as an Independent Director at WCI Communities, Inc. from 2009 to 2017, an Executive Director-Commercial Real Estate at UBS Warburg, Inc. from 1998 to 2001, an Assistant VP-Real Estate & Fixed Income at The Hartford Financial Services Group, Inc. from 1991 to 1996, a Vice President at Chase Bank USA, NA from 1996 to 1998, and an Executive VP-Investments & Head-Capital Markets at iStar, Inc. from 2003 to 2017.
She also served as an Independent Trustee at Americold Realty Trust, Inc. from 2018 to 2021.
Ms. MacKay holds an undergraduate degree from the University of Connecticut and an MBA from the University of Hartford.

Martin W.
MacKay is the founder and currently holds the position of Chairman & Chief Executive Officer at Rallybio LLC, which was founded in 2018.
He is also the Executive Chairman at Rallybio Corp., founded in 2018.
In addition to his founding positions, Dr. MacKay currently serves as the Chief Executive Officer at Calyx Group Ltd.
(Ireland) and Rallybio Holdings LLC.
He is also a Director at Charles River Laboratories International, Inc., an Independent Director at Charles River Laboratories, Inc., and an Independent Director at Novo Nordisk A since 2018.
Dr. MacKay has held former positions as the Chief Executive Officer at Vecta Software Corp.
Ltd., Neverfail, Inc., and Neverfail Ltd.
He was also a Director at Encysive Pharmaceuticals, Inc. in 2008.
Additionally, he has served as the Operations Director at The Dun & Bradstreet Corp.
and Director-Business Development at NorthgateArinso, Inc. Dr. MacKay was an Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022.
He held the position of Senior Vice President-Worldwide Development at Pfizer Inc. from 1995 to 2009 and President-Research & Development at AstraZeneca PLC from 2010 to 2013.
From 2013 to 2017, he was the Global Head-Research & Development at Alexion Pharmaceuticals, Inc. Dr. MacKay has also held positions at VeriSign, Inc., BASF Performance Products Ltd.
(United Kingdom), New Leaf Venture Partners LLC, Pfizer (St. Louis), CRI Worldwide LLC, PeopleSoft USA, Inc., Accenture LLC, Ciba-Geigy Pharmaceuticals, and Beecham Pharmaceuticals (UK).
Dr. MacKay obtained a doctorate degree from The University of Edinburgh in 1984 and an undergraduate degree from Heriot-Watt University in 1979.

Iain Rob Rayner bekleedt de functie van Joint Chief Operating Officer bij St. James's Place Plc. De heer Rayner zit ook in het bestuur van St. James's Place Acquisition Services Ltd. en St. James's Place DFM Holdings Ltd.

Iain Wetherall bekleedt de functie van Chief Investment Officer van Wizz Air Holdings Plc.

Dr. Iain D. Dukes is Chief Executive Officer bij Viriom, Inc., President & Bestuurder bij Kartos Therapeutics, Inc., Onafhankelijk Bestuurder bij Ikena Oncology, Inc., Venture Partner bij OrbiMed Advisors Private Equity, Voorzitter bij Iovance Biotherapeutics, Inc., Uitvoerend Voorzitter bij Theseus Pharmaceuticals, Inc., President bij Telios Pharmaceuticals, Inc. en President & Chief Executive Officer bij Arrys Therapeutics, Inc. Hij zetelt in de Raad van Bestuur van Angiex, Inc., ENYO Pharma SA, Kartos Therapeutics, Inc., Ikena Oncology, Inc., NeRRe Therapeutics Holdings Ltd., NeRRe Therapeutics Ltd. en ReViral Ltd. Dr. Dukes was voorheen werkzaam als Lid-Raad van Toezicht bij Themis Bioscience GmbH, als SVP & Head-Business Development bij Merck Research Laboratories Massachusetts LLC, als VP-External Research & Development bij Amgen, Inc, een President & Chief Executive Officer bij Essentialis, Inc., een VP-Scientific and Technology Licensing bij GlaxoSmithKline, Inc., een Head-Exploratory Development bij Glaxo Wellcome, Inc., een Principal bij Glaxo, Inc., en een Senior VP-Business Development & Licensing bij Merck & Co. Hij was ook lid van de raad van bestuur van KaNDy Therapeutics Ltd. Hij behaalde zijn doctoraatsdiploma aan de Universiteit van Bath, een doctoraatsdiploma aan de Universiteit van Oxford, een doctoraatsdiploma aan de Universiteit van Leeds en een doctoraatsdiploma aan de Universiteit van Oxford.

Iain G. T. Ferguson is een zakenman die aan het hoofd heeft gestaan van 11 verschillende ondernemingen en thans niet-uitvoerend voorzitter is bij Genus Plc, niet-uitvoerend voorzitter bij Crest Nicholson Holdings Plc, niet-uitvoerend voorzitter van Crest Nicholson Plc (een dochteronderneming van Crest Nicholson Holdings Plc) en voorzitter bij Hallmarq Veterinary Imaging Ltd. De heer Ferguson is tevens Chancellor aan de Cranfield University en zit in de raad van bestuur van 5 andere ondernemingen. In zijn vorige loopbaan was Iain G.T. Ferguson niet-uitvoerend voorzitter bij Stobart Group Ltd., Chief Executive Officer bij Tate & Lyle Plc, Senior Vice President-Corporate Development bij Unilever Plc, niet-uitvoerend voorzitter bij Berendsen Ltd., Chief Executive Officer bij Birds Eye Ltd., lid van PricewaterhouseCoopers Ltd., lid van de raad van bestuur van de onderneming, Lid van PricewaterhouseCoopers LLP (Verenigd Koninkrijk), Lid-Strategy Group van het Britse Department for Business, Innovation & Skills, Voorzitter van Wilton Park, Voorzitter van The Institute of Grocery Distribution en Voorzitter van The Food & Drink Federation. De heer Ferguson behaalde een bachelorgraad aan de Universiteit van St. Andrews.

Iain Michael Brown bekleedt de functie van Senior VP, Chief Financial & Accounting Officer bij Alkermes Plc. In zijn vorige loopbaan bekleedde de heer Brown de functie van Vice-President-Finance bij Alkermes, Inc. en Vice-President-Finance bij EMD Serono, Inc. Hij behaalde een bachelorgraad aan de Universiteit van Bradford.

Op dit moment bekleedt Iain Boyd de functie van Vice President-Operations Development bij Snap-On, Inc. Daarvoor bekleedde hij de functie van Vice President-Human Resources bij Snap-on Tools Co. LLC.

Iain Charles Andrew Cornish is een zakenman die aan het hoofd heeft gestaan van 6 verschillende bedrijven. Momenteel is hij voorzitter van Leeds Building Society. De heer Cornish is ook penningmeester en trustee bij Macmillan Cancer Support en zit in het bestuur van 5 andere bedrijven. Voorheen was de heer Cornish voorzitter van St. James's Place Plc, voorzitter van Shawbrook Group Plc en voorzitter van Shawbrook Bank Ltd. (een dochteronderneming van Shawbrook Group Plc), Chief Executive Officer van Yorkshire Building Society en voorzitter bij Building Societies Association. Hij heeft een bachelorgraad behaald aan de Universiteit van Southampton.

Momenteel bekleedt Iain Blacklaw de functie van Chief Operating Officer van de National Bank of Bahrain. In het verleden bekleedde hij de functie van Chief Operating Officer voor Al Rajhi Bank. Hij heeft een bachelorgraad van de Universiteit van Aberdeen.

Momenteel is Iain George Williamson Chief Executive Officer & Executive Director bij Old Mutual Ltd. en Chief Executive Officer bij Old Mutual Life Assurance Co. (South Africa) Ltd. (een dochteronderneming van Old Mutual Ltd.) en Chief Executive Officer van Old Mutual Life Assurance Co. Ltd. Hij is tevens lid van de raad van bestuur van Nedbank Group Ltd., Nedbank Ltd. en UAP Old Mutual Group Ltd. Voorheen bekleedde de heer Williamson de functie van financieel directeur van Old Mutual Emerging Markets Ltd., een dochteronderneming van Old Mutual.

Iain C. Conn is lid van de raad van bestuur van BT Group Plc en Oxford Flow Ltd. en lid van de European Round Table of Industrialists. In het verleden was de heer Conn Chief Executive Officer & Executive Director bij Centrica Plc, Executive Director & CEO-Marketing & Refining bij BP Plc en Chief Executive Officer voor BP Petrochemicals Ltd. (een dochteronderneming van BP Plc) en lid van de Raad van Bestuur van het Imperial College London. (een dochteronderneming van BP Plc) en lid van de Raad van het Imperial College London. Hij heeft een bachelorgraad van het Imperial College London.

Erick Mackay currently works as a Marketing Director at Daisy IT Managed Services Ltd.

Harvey B.
Mackay is currently the Chairman of MackayMitchell Envelope Co. and a Director of Minnesota Orchestral Association.

Mr. Kevin J.
MacKay is a Sales Associate at Computer Economics, Inc. Mr. MacKay was previously employed as Chief Accounting Officer, VP & Controller by Avaya, Inc., Chief Accounting Officer, VP & Controller by Avaya Holdings Corp., a Principal by iBASEt, a Principal by Logility, Inc., and a Principal by Oracle Corp.

Mark B.
Mackay worked as Vice President-Engineering & Construction at TransAlta Corp.
from 2012 to 2020.
Prior to that, he worked as Vice President at TransCanada PipeLines Ltd.
Mr. Mackay completed his undergraduate degree at the University of British Columbia.

Danny Colin Keith MacKay is currently the Chief Executive Officer at Tactical Software Systems Pty Ltd., Chairman at Quadrem Africa Pty Ltd., Director at Black Information Technology Empowerment Co. Ltd., and Director at Ariba South Africa.
He previously worked as a Non-Executive Director at EOH Holdings Ltd.
from 2014 to 2017.

Catherine Mackay currently works at Amplify Education, Inc., as President & Chief Operating Officer from 2018.

Jason M.
Mackay is currently a Director at Adderstone (201) Ltd.
Prior to this, he was a Non-Executive Director at Audioboom Group Plc from 2014 to 2017.
He also held positions as Head of UK Equities at GLG Partners LP and Co-Head of UK Equities at Man Group Investments Ltd.
from 2004 to 2010.

Mr. Steve Mackay is Chief Financial Officer at Pumpkin Patch Ltd.

Mr. Tom Mackay is a Senior Independent Non-Executive Director at Aminex Plc.
He is on the Board of Directors at Aminex Plc and Upstream Solutions Ltd.
Mr. Mackay was previously employed as a Manager-Existing Ventures by Clyde Petroleum Plc, a Partner by Gemini Oil & Gas Advisors LLP, a Chief Executive Officer & Director by Oilquest Ltd., and a General Manager by Stratic Energy Corp.
He also served on the board at Oil Quest Holdings Ltd.
He received his undergraduate degree from the University of Durham.

Douglas Duffy MacKay held the following former jobs: Senior VP-Scientific & Regulatory Affairs at CV Sciences, Inc. from 2019 to 2021, Senior VP-Scientific & Regulatory Affairs at Council for Responsible Nutrition from 2008 to 2018, and Vice President-Clinical Research at Nordic Pharma, Inc. AS from 2004 to 2008.
He received his undergraduate degree from the University of California, Santa Cruz in 1994 and his doctorate degree from National College of Natural Medicine in 2001.

James M.
Mackay is the founder of Aristea Therapeutics, Inc. (founded in 2018) where he holds the title of President & Chief Executive Officer.
He is currently the Chairman at CONNECT since 2014, Director at BIOCOM, Director at MatriSys Bioscience, Inc. (since 2020), Director at Arthrosi Therapeutics, Inc. (since 2021), and Independent Director at Privo Technologies, Inc. Dr. Mackay previously served as President & Chief Executive Officer at Ardea Biosciences, Inc. (2013-2018), Director & Trustee at San Diego Regional Economic Development Corp.
(2017-2018), and Vice President-Global Product at AstraZeneca PLC (2008-2016).
He obtained undergraduate and doctorate degrees from the University of Aberdeen.

Giles Patrick Cyril Mackay is currently a Director at ResiManagement Ltd., PXS 3 Ltd., Heylo Housing Secured Bond Plc, Heylo Housing Group Ltd., GPCM Holdco Ltd., GPCM Finco Ltd., Statuslist Ltd., Worthearly Ltd., Assettrust Ltd., HH No.
3 Ltd., HH No.
2 Ltd., and HH No.
5 Ltd.
He was formerly a Director at Hometrack Co. UK Ltd.

Billy Mackay is the founder of Boon Co., Inc. He is currently working as the Managing Director-Advised at AJ Bell Plc.

Thomas Mackay is currently the Chief Financial Officer, Director & SVP at Virgin Atlantic Airways Ltd.
He is also a Director at Virglease Ltd., Virgin Travel Group Ltd., Virglease (3) Ltd., Junopart Ltd., VA Cargo Ltd., Virgin Atlantic Two Ltd., and Virgin Atlantic International Ltd.
Previously, he served as the Chief Financial Officer & Director at Virgin Atlantic Ltd.

Ian Mackay is the founder of Manaccom Pty Ltd.
He previously worked as the Executive Deputy Chairman at Jumbo Interactive Ltd.

Malcolm MacKay currently works at Sheltering Arms Children & Family Services, Inc., as Director.

Colin Mackay currently works at Elian Fiduciary Services (Cayman) Ltd., as Chief Executive Officer from 2011 and Maclay Murray & Spens LLP.
Mr. Mackay also formerly worked at EMR Capital Pty Ltd., as Board Director and Ogier Group LP, as Partner.
Mr. Mackay received his graduate degree in 1991 from the University of Glasgow.

Mark R.
MacKay is currently a Director at Attune Consulting USA LLC since 2013.
Prior to this, he held various Principal and Vice President positions at companies such as The Black & Decker Corp., Everlast Worldwide, Inc., The Basketball Marketing Co., Inc., The Rockport Co. LLC, L'Oréal USA, Inc., Philip Morris USA, Inc., Under Armour, Inc., Icpw Liquidation Corp., and Reebok USA Ltd.

Andrew Ryan MacKay is currently working as a Vice President & Global Credit Strategist at Loomis, Sayles & Co. LP.
He started this job in 2018.
In terms of education, Mr. MacKay completed his undergraduate degree at the University of New Hampshire.
He also obtained an MBA from the Wallace E Carroll School of Management in 2002.

Gavin Mackay worked as Head of Investor Relations and Business Development at Aquarius Platinum Ltd.
in 2011 and as Head of Business Development and Investor Relations at Ferrexpo Plc.
Mr. Mackay completed his undergraduate degree at the University of Cape Town and his graduate degree at the University of the Witwatersrand.